Inspection Data Reveals US/EU Mutual Recognition Agreement's Impact On China and India
Executive Summary
The agreement reached in the early days of the Trump administration has been putting China and India drug manufacturing in the crosshairs of the world’s leading pharmaceutical inspectorates.